Insurer Globe Life beats Q3 revenue estimates; cuts FY forecast

By Reuters News


Overview

  • U.S. life and health insurer's Q3 revenue beat analyst expectations, premium revenue grew 7% yr/yr

  • Net operating income per share rose slightly from prior year

  • Company repurchased 1.1 mln shares for $185 mln during the quarter


Outlook

  • Globe Life lowers 2026 net operating income guidance to $15.35-$15.65 per share due to two items impacting results at United American General Agency division

  • Company expects 2027 net operating income per share of $16.10-$17.10

  • Globe Life raises 2026 share repurchase target to $725 mln-$775 mln from $670 mln-$700 mln


Result Drivers

  • PREMIUM REVENUE GROWTH - Co said total premium revenue rose 7% yr/yr, driven by increases in both life and health insurance premiums

  • HEALTH SEGMENT - Co said health premium and underwriting margin rose, led by growth at the Family Heritage Division

  • AGENT GROWTH - Liberty National Division saw a 9% increase in average producing agent count, supporting higher life net sales and premiums


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$1.6 bln

$1.54 bln (4 Analysts)

Q3 EPS

$4.62


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the life & health insurance peer group is "hold."

  • Wall Street's median 12-month price target for Globe Life Inc. is $192.00, about 13.1% above its October 20 closing price of $169.72

  • The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago


Reuters Recommended Reads

  • Oct 20 - Insurance firm Chubb Q3 net income rises

  • Oct 20 - Social inflation deepens pressure on US liability insurers: AM Best

  • Oct 20 - GE Aerospace Q3 adjusted revenue beats on strong demand; lifts 2026 outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.